<DOC>
	<DOCNO>NCT02981888</DOCNO>
	<brief_summary>The purpose study find relationship bile acid , fatty acid ( fatty acid part diet ) bacteria present intestine .</brief_summary>
	<brief_title>Fecal Bile Acids , Fecal Short Chain Fatty Acids Intestinal Microbioita Patients With IBS Control Volunteers</brief_title>
	<detailed_description>There emerge evidence alteration bile acid SCFA associate IBS could associate change gut microbiota . In addition modulating level intraluminal organic acid , hypothesize gut microbiota may alter local immune response , modulate visceral pain response , impair gut barrier function . Our overall goal investigate relationship fecal bile acid , SCFA gut microbiota IBS . Results pilot study could reveal insight interplay gut microbiota small molecule mediator IBS suggest target clinical strategy improve diagnosis management important syndrome . AIM 1 : Test hypothesis fecal organic acid ( SFCA bile acid ) fecal microbiota play important role IBS . AIM 2 : Test hypothesis association colonic transit fecal microbiota IBS</detailed_description>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Patients IBS , age 1865 fulfil Rome IV criterion asymptomatic control prior history GI disease symptom . Participants stable consistent diet regimen follow extreme diet intervention glutenfree low FODMAP diet time study participation . Participants microscopic/lymphocytic/collagenous colitis , inflammatory bowel disease , celiac disease , cancer , chronic infectious disease , immunodeficiency , uncontrolled thyroid disease , history liver disease history elevate AST/ALT &gt; 2.0x upper limit normal Prior radiation therapy abdomen abdominal surgery exception appendectomy cholecystectomy &gt; 6 month prior study initiation Ingestion prescription , counter , herbal medication affect GI transit study interpretation ( e.g . opioids , narcotic , anticholinergic , tricyclic antidepressant , serotonin norepinephrine reuptake inhibitor , nonsteroidal antiinflammatory drug , COX2 inhibitor , bile acid sequestrants ) within 6 month study initiation asymptomatic volunteer within 2 day study initiation IBS patient Any female pregnant try become pregnant breastfeeding Antibiotic usage within 3 month prior study participation Prebiotic probiotic usage within 2 week prior study initiation Use tobacco product within past 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>